Biomarin Pharmaceutical Inc (BMRN)
Cash conversion cycle
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 873.02 | 781.10 | 767.08 | 775.41 | 742.72 | 832.16 | 799.82 | 763.05 | 722.52 | 698.64 | 667.91 | 674.72 | 643.53 | 631.98 | 614.19 | 602.50 | 573.56 | 461.62 | 488.84 | 486.33 |
| Days of sales outstanding (DSO) | days | 93.23 | 101.97 | 91.45 | 84.48 | 103.10 | 97.47 | 94.09 | 95.61 | 90.44 | 99.68 | 100.43 | 80.33 | 76.26 | 89.07 | 83.53 | 73.82 | 74.03 | 80.83 | 78.39 | 87.96 |
| Number of days of payables | days | 246.13 | 181.14 | 176.75 | 148.08 | 196.69 | 180.98 | 205.40 | 217.44 | 210.96 | 199.05 | 192.45 | 174.50 | 158.81 | 156.95 | 146.69 | 149.72 | 155.61 | 266.94 | 273.36 | 133.27 |
| Cash conversion cycle | days | 720.12 | 701.93 | 681.78 | 711.80 | 649.12 | 748.65 | 688.52 | 641.22 | 602.00 | 599.26 | 575.88 | 580.55 | 560.98 | 564.10 | 551.03 | 526.60 | 491.98 | 275.51 | 293.87 | 441.02 |
September 30, 2025 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 873.02 + 93.23 – 246.13
= 720.12
Peer comparison
Sep 30, 2025
Company name
Symbol
Cash conversion cycle
Biomarin Pharmaceutical Inc
BMRN
720.12
Arrowhead Pharmaceuticals Inc
ARWR
-364.74
Regeneron Pharmaceuticals Inc
REGN
557.88